These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30276573)

  • 21. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas.
    Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T
    Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
    Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
    Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular thymidylate synthase inhibition by trifluorothymidine in FM3A cells.
    Temmink OH; Comijn EM; Fukushima M; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1491-4. PubMed ID: 15571283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.
    Ando T; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Sugito N; Mori R; Ogawa R; Katada T; Fujii Y
    Dis Esophagus; 2008; 21(1):15-20. PubMed ID: 18197934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil.
    Kodera Y; Ito S; Fujiwara M; Mochizuki Y; Nakayama G; Ohashi N; Koike M; Yamamura Y; Nakao A
    Cancer Lett; 2007 Jul; 252(2):307-13. PubMed ID: 17303323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
    Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ
    World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil.
    Tahara M; Ochiai A; Fujimoto J; Boku N; Yasui W; Ohtsu A; Tahara E; Yoshida S
    Oncol Rep; 2004 Jan; 11(1):9-15. PubMed ID: 14654896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.
    Inaba M; Naoe Y; Mitsuhashi J
    Biol Pharm Bull; 1998 Jun; 21(6):569-73. PubMed ID: 9657039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
    Emura T; Nakagawa F; Fujioka A; Ohshimo H; Kitazato K
    Oncol Rep; 2004 Feb; 11(2):381-7. PubMed ID: 14719072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
    Ijuin T; Nibu K; Doi K; Inoue H; Saitoh M; Ohtsuki N; Makino K; Amatsu M
    Acta Otolaryngol; 2007 Mar; 127(3):305-11. PubMed ID: 17364369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis.
    Marchetti S; Chazal M; Dubreuil A; Fischel JL; Etienne MC; Milano G
    Br J Cancer; 2001 Aug; 85(3):439-45. PubMed ID: 11487278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, orotate phosphoribosyltransferase mRNA expression in lung cancer metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration: a pilot study.
    Nakajima T; Yasufuku K; Suzuki M; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
    Clin Lung Cancer; 2011 Sep; 12(5):293-7. PubMed ID: 21791367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Fluorouracil-related gene expression in hepatic artery infusion-treated patients with hepatic metastases from colorectal carcinomas.
    Sameshima S; Tomozawa S; Horikoshi H; Motegi K; Hirayama I; Koketsu S; Okada T; Kojima M; Kon Y; Sawada T
    Anticancer Res; 2008; 28(1B):389-93. PubMed ID: 18383874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites.
    Wang T; Wang L; Qian X; Yu L; Ding Y; Liu B
    Cancer Invest; 2011 Feb; 29(2):130-6. PubMed ID: 21210725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate.
    de Bruin M; van Capel T; Smid K; van der Born K; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1485-90. PubMed ID: 15571282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN gamma-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in bladder cancer cells.
    Li G; Kawakami S; Kageyama Y; Yan C; Saito K; Kihara K
    Anticancer Res; 2002; 22(5):2607-12. PubMed ID: 12529971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitization by thymidine phosphorylase inhibitor in thymidine phosphorylase negative and overexpressing bladder cancer cell lines.
    El-Naggar M; Ebbing E; Bijnsdorp I; van den Berg J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):413-21. PubMed ID: 24940699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.